Who is sponsoring NCT04238468?

NCT04238468 is sponsored by Katarina Zivec.

What drugs are being tested in NCT04238468?

Interventions in NCT04238468: Intradermal stromal vascular fraction injection.

What condition does NCT04238468 study?

NCT04238468 studies Wound Heal, Scar, Hypertrophic Scar, Delayed Wound Healing.

Is NCT04238468 still recruiting?

NCT04238468 is currently status unknown. Last updated 24 March 2020.

Last reviewed 2020-03-24 · How we verify

NCT04238468

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Scar Tissue Analysis After Intraoperative Application of Stromal Vascular Fraction Cells Into Suture Line

Status unknown NA Last updated 24 March 2020

What this trial tests

NA trial testing Intradermal stromal vascular fraction injection in Wound Heal in 20 participants. Status unknown.

Timeline

1 April 2018

Primary endpoint
30 April 2020

10 October 2020

Quick facts

Lead sponsor	Katarina Zivec
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	20
Start date	1 April 2018
Primary completion	30 April 2020
Estimated completion	10 October 2020
Sites	1 location across Slovenia

Drugs / interventions tested

Intradermal stromal vascular fraction injection

Conditions studied

Wound Heal — all drugs for Wound Heal →
Scar — all drugs for Scar →
Hypertrophic Scar — all drugs for Hypertrophic Scar →
Delayed Wound Healing — all drugs for Delayed Wound Healing →

Sponsor

Katarina Zivec

Who can join

Adults 20 to 65, female only, with Wound Heal or Scar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will evaluate the effect of intradermal injection of stromal vascular fraction into suture line on wound healing and scarring.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Wound Heal

Currently open trials in the same condition.

NCT07261501 — An Exploratory Research on the Efficacy and Safety of Antibacterial Absorbable Dressing in Chronic Non-healing Wounds · NA · recruiting
NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
NCT06522438 — Hyaluronic Acid and Octenidine Gel as an Adjunct to Non-surgical Periodontal Treatment · NA · recruiting
NCT06841237 — Randomized Controlled Trial on the Efficacy and Safety of Xiang Lei Ointment in Diabetic-related Ulcer Management · NA · recruiting
NCT06563323 — Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04238468 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Katarina Zivec
Last refreshed: 24 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04238468.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing